These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 19670916)

  • 1. First-generation drug-eluting stents ... and beyond.
    Wijns W
    Drug Saf; 2009; 32(9):771-3. PubMed ID: 19670916
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug-eluting stents: limitations of early generation and progress with newer generation devices.
    Khattab AA; Windecker S
    Minerva Med; 2010 Feb; 101(1):9-23. PubMed ID: 20228717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expectation for new-generation drug eluting stents].
    Saito S
    Nihon Rinsho; 2011 Feb; 69(2):237-9. PubMed ID: 21387669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The bioabsorbable stent as a virtual prosthesis.
    Colombo A; Sharp AS
    Lancet; 2009 Mar; 373(9667):869-70. PubMed ID: 19286066
    [No Abstract]   [Full Text] [Related]  

  • 5. [Coronary stents: what is new?].
    Zeus T; Münzel T
    Dtsch Med Wochenschr; 2014 Apr; 139(14):701-3. PubMed ID: 24668429
    [No Abstract]   [Full Text] [Related]  

  • 6. Dexamethasone-eluting vascular stents.
    Hämäläinen M; Nieminen R; Uurto I; Salenius JP; Kellomäki M; Mikkonen J; Kotsar A; Isotalo T; Teuvo Tammela LJ; Talja M; Moilanen E
    Basic Clin Pharmacol Toxicol; 2013 May; 112(5):296-301. PubMed ID: 23374962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of drug-eluting stents.
    Kukreja N; Onuma Y; Daemen J; Serruys PW
    Pharmacol Res; 2008 Mar; 57(3):171-80. PubMed ID: 18339557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of drug-eluting stents for the treatment of coronary chronic total occlusions.
    Brilakis ES; Kotsia A; Luna M; Garcia S; Abdullah SM; Banerjee S
    Expert Rev Cardiovasc Ther; 2013 Oct; 11(10):1349-58. PubMed ID: 24138522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-eluting versus bare-metal coronary stents: where are we now?
    Amoroso NS; Bangalore S
    J Comp Eff Res; 2012 Nov; 1(6):501-8. PubMed ID: 24236469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary stents: looking forward.
    Garg S; Serruys PW
    J Am Coll Cardiol; 2010 Aug; 56(10 Suppl):S43-78. PubMed ID: 20797503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A critical appraisal of the safety and efficacy of drug-eluting stents.
    Maluenda G; Lemesle G; Waksman R
    Clin Pharmacol Ther; 2009 May; 85(5):474-80. PubMed ID: 19279567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new generation of drug-eluting stents: Indications and outcomes of bioresorbable vascular scaffolds.
    Waksman R
    Cleve Clin J Med; 2017 Dec; 84(12 Suppl 4):e20-e24. PubMed ID: 29281608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary stents: current status.
    Garg S; Serruys PW
    J Am Coll Cardiol; 2010 Aug; 56(10 Suppl):S1-42. PubMed ID: 20797502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioresorbable Stents in PCI.
    Lindholm D; James S
    Curr Cardiol Rep; 2016 Aug; 18(8):74. PubMed ID: 27312934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014.
    Byrne RA; Joner M; Kastrati A
    Eur Heart J; 2015 Dec; 36(47):3320-31. PubMed ID: 26417060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New drug-eluting stent concepts.
    Wessely R
    Nat Rev Cardiol; 2010 Apr; 7(4):194-203. PubMed ID: 20195268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential solutions to the current problem: coated balloon.
    Scheller B; Speck U
    EuroIntervention; 2008 Aug; 4 Suppl C():C63-6. PubMed ID: 19202699
    [No Abstract]   [Full Text] [Related]  

  • 18. Update on drug-eluting stents for prevention of restenosis.
    Lee CH; Tan HC; Lim YT
    Asian Cardiovasc Thorac Ann; 2006 Feb; 14(1):75-82. PubMed ID: 16432127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-eluting stents at a crossroads: the good, the bad and the ugly.
    Nammas W
    Future Cardiol; 2012 Jan; 8(1):1-3. PubMed ID: 22185439
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of everolimus- and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds.
    Puricel S; Arroyo D; Corpataux N; Baeriswyl G; Lehmann S; Kallinikou Z; Muller O; Allard L; Stauffer JC; Togni M; Goy JJ; Cook S
    J Am Coll Cardiol; 2015 Mar; 65(8):791-801. PubMed ID: 25720622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.